Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study
about
The claudin gene family: expression in normal and neoplastic tissuesTight Junctions and the Tumor MicroenvironmentAlterations of the apical junctional complex and actin cytoskeleton and their role in colorectal cancer progressionParadigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesisClaudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapyDifferential expression and subcellular localization of claudin-7, -8, -12, -13, and -15 along the mouse intestineRegulation of tight junction assembly and epithelial morphogenesis by the heat shock protein Apg-2Disturbed expression of E-cadherin, beta-catenin and tight junction proteins in colon carcinoma is unrelated to growth pattern and genetic polymorphisms.Expression of claudin 1, 4 and 7 in thyroid neoplasms.Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 ExpressionClaudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers.Claudin-1 Expression Is Elevated in Colorectal Cancer Precursor Lesions Harboring the BRAF V600E Mutation.Gastrointestinal mucosal barrier function and diseases.Claudin-3 overexpression increases the malignant potential of colorectal cancer cells: roles of ERK1/2 and PI3K-Akt as modulators of EGFR signaling.Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front.Role of Estrogen Receptor-α in the Regulation of Claudin-6 Expression in Breast Cancer CellsExpression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladder.Differential expression of claudin family proteins in mouse ovarian serous papillary epithelial adenoma in aging FSH receptor-deficient mutantsDysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cellsAnalysis of Snail-1, E-cadherin and claudin-1 expression in colorectal adenomas and carcinomas.Claudin-1, but not claudin-4, exhibits differential expression patterns between well- to moderately-differentiated and poorly-differentiated gastric adenocarcinoma.Expression of claudin-5, -7, -8 and -9 in cervical carcinoma tissues and adjacent non-neoplastic tissues.Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancerApoptosis signal-regulating kinase 1 is associated with the effect of claudin-6 in breast cancer.Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug deliveryClaudin 1 and Claudin 7 Gene Polymorphisms and Protein Derangement are Unrelated to the Growth Pattern and Tumor Volume of Colon CarcinomaClaudin-7 increases chemosensitivity to cisplatin through the upregulation of caspase pathway in human NCI-H522 lung cancer cells.Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomasClaudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformationNm23H1 mediates tumor invasion in esophageal squamous cell carcinoma by regulation of CLDN1 through the AKT signaling.P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cellsEmerging roles of claudins in human cancerThe claudin family of proteins in human malignancy: a clinical perspectiveExpression transformation of claudin-1 in the process of gastric adenocarcinoma invasion.The claudins.Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases -2 expression in ovarian carcinoma.Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.Claudin and ovarian cancer.Na+/H+ exchanger 1 has tumor suppressive activity and prognostic value in esophageal squamous cell carcinoma.Claudin expression in high-grade invasive ductal carcinoma of the breast: correlation with the molecular subtype.
P2860
Q21260426-C744BF55-A91A-465C-B340-DEA0FCE62F6BQ26740056-055981D1-3599-4449-BB6E-6683E6875F54Q26785540-03D4579A-DC68-4099-89F7-4B0F95B83B02Q26787279-D3E53624-F70B-4768-95C3-9B4BD31046EAQ26851347-19E7AD1D-450F-443A-9DAC-FAF2FE87926EQ28509306-B038E172-0079-47A2-A14C-F273E1DB4B30Q33306608-D436A6CB-9723-4ABA-84FC-BE61682A64ECQ33327299-B6AEA7D1-15DD-4540-A262-1793A92189F3Q33686147-79C8229D-8788-44CC-8B4B-99FE06ED5361Q33838977-6C1ABF07-D79A-4EAA-BF53-782D123EC0D4Q33856016-847FCDEF-0745-457B-93F8-829349E277DBQ34369345-EAB1506E-5325-4B52-B33D-D975EA92E5C0Q34520959-32D4391A-695C-4693-9609-3BDC0D4880BFQ34999421-EDB53A03-EAA3-4D03-B5AB-3D4530118D3CQ35000704-37C63ACE-1CEE-49FB-BEE4-6C783C2E7246Q35142103-BD8EDA30-2799-4FC1-B1DF-DC0EF14A5895Q35440688-B6689F3C-97EF-4A65-96E7-89DA216AF00CQ35613198-373E83D6-934E-42AF-A043-4300EBF908E4Q35750120-42FF31AF-B881-4ADB-9899-7144AE5FF951Q35795767-98CC3C9B-F28F-4B26-8C9E-6629034CBC40Q35803558-0B5C16C7-741D-4747-A17C-7C1BB2B8A061Q36095370-3961539C-ACE9-42A5-949B-9DCAF9C1733AQ36334806-99B72F6D-6227-4802-8C81-EEFC28B2291CQ36367870-AAFCD18F-9811-4A8D-B0F4-1AE844560CF2Q36544167-125666B8-283B-49B6-A966-71E9DAC7B251Q36735466-D92523E1-B48C-426B-8DCE-98CF9ABA2DBBQ36773956-5233B897-5DAC-49FE-B674-2A3BCC90DCB6Q36796253-E277708A-A0B0-4D0E-975D-AF4627FA0273Q36982054-2421A55E-16EF-4BC1-A0CD-61E415667151Q37150537-0724D433-F326-46CA-92CB-DC385BF06912Q37182251-D948002E-0C37-4949-8923-32B6408FFBC7Q37225107-5078B446-1637-4B45-8342-55F8E86198DFQ37302556-DB1DB2B1-3ED7-428C-B291-0C5DFA91B2F9Q37338056-BE181A55-A6F7-4CF0-8C4A-B3A8E15A06D7Q37350823-DB362682-F371-4058-A711-E40B793F4CD7Q37400120-F7400786-DCB8-42B5-A2ED-0C523C0ABA2AQ37492166-F94469B0-C0A7-4B0B-9084-D658C6CE9694Q37611453-FB20413D-2E69-4A67-8D65-FB04680A6AE6Q37709248-64DB5FBF-06F7-43E2-B1B9-A9E2F5B4C2BEQ37725542-2D9D04F9-DBBB-4496-B673-F738AB07FD90
P2860
Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Claudin-1 is a strong prognost ...... cer: a tissue microarray study
@ast
Claudin-1 is a strong prognost ...... cer: a tissue microarray study
@en
Claudin-1 is a strong prognost ...... cer: a tissue microarray study
@nl
type
label
Claudin-1 is a strong prognost ...... cer: a tissue microarray study
@ast
Claudin-1 is a strong prognost ...... cer: a tissue microarray study
@en
Claudin-1 is a strong prognost ...... cer: a tissue microarray study
@nl
prefLabel
Claudin-1 is a strong prognost ...... cer: a tissue microarray study
@ast
Claudin-1 is a strong prognost ...... cer: a tissue microarray study
@en
Claudin-1 is a strong prognost ...... cer: a tissue microarray study
@nl
P2093
P2860
P3181
P1433
P1476
Claudin-1 is a strong prognost ...... cer: a tissue microarray study
@en
P2093
Edmond Sabo
Justin Routhier
Murray B Resnick
Tamako Konkin
Victor E Pricolo
P2860
P2888
P3181
P356
10.1038/MODPATHOL.3800301
P407
P577
2005-04-01T00:00:00Z
P5875
P6179
1048169621